[Monitoring of patients using atypical psychotics and screening for metabolic syndrome].
作者信息
Legrix Dorothée
机构信息
EPSM Lille-Métropole.
出版信息
Soins Psychiatr. 2010 Jan-Feb(266):25-9.
PMID:20162964
Abstract
摘要
相似文献
1
[Monitoring of patients using atypical psychotics and screening for metabolic syndrome].[使用非典型抗精神病药物的患者监测及代谢综合征筛查]
Soins Psychiatr. 2010 Jan-Feb(266):25-9.
2
Challenges in advancing mental and physical health of patients with serious mental illness.促进严重精神疾病患者身心健康所面临的挑战。
J Psychopharmacol. 2005 Nov;19(6 Suppl):3-5. doi: 10.1177/0269881105058969.
3
Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.生物学视角。代谢综合征：精神分裂症与非典型抗精神病药物。
Perspect Psychiatr Care. 2006 Aug;42(3):204-7. doi: 10.1111/j.1744-6163.2006.00073.x.
4
Metabolic and lifestyle issues and severe mental illness--new connections to well-being?代谢与生活方式问题及严重精神疾病——与幸福安康的新关联？
J Psychopharmacol. 2005 Nov;19(6 Suppl):188-22.
5
Medical risk in patients with bipolar disorder and schizophrenia.双相情感障碍和精神分裂症患者的医疗风险。
J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42.
6
[Increased risk of cardiovascular diseases and diabetes in mentally ill persons. Life style is a contributing factor].[精神病患者患心血管疾病和糖尿病的风险增加。生活方式是一个促成因素]
Lakartidningen. 2003 Jul 10;100(28-29):2353-5.
7
Metabolic syndrome and cardiovascular disease.代谢综合征与心血管疾病。
J Psychopharmacol. 2005 Nov;19(6 Suppl):84-93. doi: 10.1177/0269881105058375.
8
Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.患有严重且持续性精神疾病的成年人中的肥胖问题：对假定机制和当前干预措施的综述
Ann Clin Psychiatry. 2011 May;23(2):131-40.
9
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.双相情感障碍患者的治疗药物及心血管疾病风险监测
J Affect Disord. 2007 Sep;102(1-3):145-51. doi: 10.1016/j.jad.2007.01.006. Epub 2007 Feb 5.
10
Metabolism, lifestyle and bipolar affective disorder.新陈代谢、生活方式与双相情感障碍。
J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. doi: 10.1177/0269881105058678.
Zotero 插件